{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:42:00Z","timestamp":1761597720532},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.transproceed.2016.01.021","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T12:29:14Z","timestamp":1466166554000},"page":"1208-1211","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report"],"prefix":"10.1016","volume":"48","author":[{"given":"G.W.","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.L.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.S.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.01.021_bib1","first-page":"77","article-title":"Management of CMV infection and disease in transplant patients","volume":"11","author":"Razonable","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.transproceed.2016.01.021_bib2","first-page":"60","article-title":"Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections","volume":"10","author":"Razonable","year":"2003","journal-title":"Herpes"},{"key":"10.1016\/j.transproceed.2016.01.021_bib3","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3748\/wjg.14.4849","article-title":"Cytomegalovirus infection after liver transplantation: current concepts and challenges","volume":"14","author":"Razonable","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2016.01.021_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/AAC.33.5.736","article-title":"Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome","volume":"33","author":"Jacobson","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2016.01.021_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","article-title":"Foscarnet nephrotoxicity: mechanism, incidence and prevention","volume":"9","author":"Deray","year":"1989","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2016.01.021_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.1840070311","article-title":"The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation","volume":"7","author":"Ludwig","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2016.01.021_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-125-7-199610010-00008","article-title":"Cytomegalovirus encephalitis","volume":"125","author":"Ariribas","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2016.01.021_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s004280100497","article-title":"Presence of occult cytomegalovirus infection in the brain after orthotopic liver transplantation: an autopsy study of 83 cases","volume":"440","author":"Ribalta","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.transproceed.2016.01.021_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.44.3_Part_1.507","article-title":"Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS)","volume":"44","author":"Holland","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.transproceed.2016.01.021_bib10","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/infdis\/171.6.1603","article-title":"Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid","volume":"171","author":"Cinque","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2016.01.021_bib11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/infdis\/170.5.1275","article-title":"diagnosis of human cytomegalovirus infection of the central nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients","volume":"170","author":"Revello","year":"1994","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2016.01.021_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/clpt.1986.177","article-title":"Human pharmacokinetics of the antiviral durg DHPG","volume":"40","author":"Fletcher","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2016.01.021_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/AAC.23.5.676","article-title":"Antiherpesvirus activity of the acyclic nucleoside 9-(1,3-dihyddroxy-2-propoxymethyl)quinine","volume":"23","author":"Smee","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2016.01.021_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00042560-199904010-00005","article-title":"Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations","volume":"20","author":"Aweeka","year":"1999","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.transproceed.2016.01.021_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/164.4.785","article-title":"Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring","volume":"164","author":"MacGregor","year":"1991","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2016.01.021_bib16","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1128\/AAC.37.9.1777","article-title":"Penetration of foscarnet into cerebrospinal fluid of AIDS patients","volume":"37","author":"Raffi","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2016.01.021_bib17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.37.5.1010","article-title":"Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis","volume":"37","author":"Hengge","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2016.01.021_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/AAC.33.7.1023","article-title":"Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection","volume":"33","author":"Sjovall","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2016.01.021_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.34.2.373","article-title":"Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in\u00a0vitro","volume":"34","author":"Manischewitz","year":"1990","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T05:53:33Z","timestamp":1536645213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0041134516001883"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.021","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}